The company is developing bone re-growth stimulation technologies and has an adaptive stem cell line called Marrow Isolated Adult Multi-Lineage Inducible cells. Vivex aims to introduce its stem cell and implant technologies to the market by early 2014.
More Articles on Devices:
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
Trinity Orthopedics Acquires Expanding Concepts’ Patent Portfolio
8 Key Notes on Spine & Orthopedic Medical Device Companies
